Commotion: Trump Promotes Regeneron

Following President Trump’s diagnosis of COVID-19 and subsequent hospitalization at the Walter Reed Medical Center, he received an experimental drug treatment in addition to the usual therapy for the disease. This medication has apparently been effective, as on October 7, 2020 physicians from the White House reported that Trump has not experienced any symptoms for the past 24 hours. As part of his treatment, Trump received a cocktail of monoclonal antibodies named REGN-COV2. He also received doses of Remdesivir (an antiviral medication) and Dexamethasone (a steroid). Many on social media discussed the drug and its potential use as a COVID-19 cure.